Revolutionising Tissue Fabrication with HITS-Bio
Penn State researchers have fabricated high-throughput integrated tissue fabrication system for bioprinting at record speed with the use of a spheroid-based tissue-constructing system. The future-changing tissue engineering system which has filled the gap that existed between research and clinical applications is the fact that the system is capable of accomplishing unmatchable efficiency levels and production of complex tissues that are ten times faster than what exists presently and cell viability which is kept above 90%.
How HITS-BioWorks: Precision Meets Speed
At the center is a digital nozzle array which is dynamically able to manipulate hundreds of spheroids in a controlled way. It presents a new mechanism as it relates to constructing scalable tissue constructs with unmatched precision. As such, for instance, one can now assemble a one cubic centimeter structure of cartilage within less than 40 minutes by using 600 spheroids through the use of this system. This would be supplemented by further rat models, which demonstrated that spheroids were printed into a skull wound site in direct intraoperative bioprinting as spheroids. Those spheroids would become bone tissue using microRNA technology; three weeks post implantation, 91% of the wound healed and at six weeks, it had reached 96%. Senior researcher Ibrahim T. Ozbolat added that “This technique is a big deal in terms of high throughput tissue fabrication with high cell viability by rapid bioprinting of spheroids.”.
Overcoming Key Challenges in Tissue Engineering
HITS-Bio holds a bright promise of overcoming significant challenges in tissue biofabrication such as ensuring high density and precise placement of spheroids, both critical to replicating the architecture and functionality of tissues in the natural state. The technology has a very important potential to reduce fabrication time to feasible throughputs, thus opening up the development of functional tissues and organs for clinical use or transplantation.
The method also addresses cost and scalability challenges inherent in bioprinting. HITS-Bio, integrating an advanced imaging system and multiarray nozzle system, enables a practical solution for large-scale tissue fabrication, which further brings researchers closer to replicating organ-specific structures.
Scaling Bioprinting Innovation
Future developments for HITS-Bio will be focused on vascularization of fabricated tissues-a very important step towards viable, functional organs. The nozzle array will be scaled up to accept larger, more intricately patterned structures which should lead to further innovations in the area of regenerative medicine and tissue engineering.
With the capability of reaching cell densities with physiological relevance and efficiently repairing volumetric defects, HITS-Bio has the potential to revolutionize treatment approaches for complex injuries and diseases. Applications include tissue such as cartilage and bone tissues, and other scalable means to meet increasing demand for organ transplantation and regenerative therapies.
A New Era in Bioprinting
The work of HITS-Bio is truly inspiring since they can rewrite bounds in bioprinting. The system tackles some of the main challenges in tissue engineering with its balancing act of speed, precision and scalability. If successful in preclinical models, it shows the potential for clinical translation, bringing us one step closer to a future where on-demand bioprinted tissues are readily available.
This innovation is an example of the power of interdisciplinary research and technology in the context of real problems being worked on, enabling a breakthrough in advancement in medicine and biotechnology.
Know more about this article here.
